Methanol Extract of Peltophorum pterocarpum Stem Bark Has Antimalarial Activity and Normalizes Biochemical Changes Induced by Plasmodium berghei Infection

This study evaluated the antimalarial, haematological and biochemical status of Plasmodium berghei Anka 65-infected mice treated with methanol extract of Peltophorum pterocarpum stem bark (MEPT). The acute toxicity profile and phyto-constituents were also evaluated. Thirty mice were divided into 6 groups of 5 mice each. Group 1 served as normal control and received distilled water only. Group 2 was parasitized and untreated. Groups 3-5 were parasitized and treated with 200, 400 and 600 mg/kg b.w. body weight of MEPT respectively. Group 6 was parasitized and treated with 28 mg/kg. b.w. of arthemeter/lumenfantrin combination. Malaria parasitemia were monitored on treatment days 0-3. Antioxidant, liver, kidney and lipid peroxidation status were determined using classical methods 5 days post-treatment. There were dose-dependent reductions in malaria parasitemia percentages of groups 3-5 that are comparable with group 6. In addition, there were dose and duration-dependent increases in malaria chemo-suppression in groups 3-5. The existence of oxidative stress, lipid peroxidation, and kidney and liver dysfunctions were observed in group 2 when compared with group 1. Treatment of groups 3-5 with MEPT and group 6 with arthemeter/lumenfantrin for 4 days restored the biochemical anomalies induced by malaria. The extract was tolerable up to 5,000 mg/kg b.w. of MEPT. The presence of flavonoids, alkaloids, saponins, tannins, steroids, carotenoids, glycosides, anthraquinones, terpenoids and anthocyanins were detected in high amounts while phenols was detected in low amount in MEPT. These suggest that MEPT possesses antimalarial activity and normalizes malaria-modified biochemical changes. These effects might be attributed to its bioactive constituents. Keywords: malaria, Peltophorum pterocarpum, phytochemicals, toxicity, biochemical dysfunctions DOI: 10.7176/ALST/73-05 Publication date: April 30th 201

Phytoglycoproteins and Human Health: Current Knowledge and Future Applications

Over the years, humans have relied on plants as sources of nutrients and bioactive compounds that promote health and wellness. Interestingly, drug discovery has benefitted immensely from the use of bioactive phytochemicals derived from food and medicinal plants. Phytoglycoproteins (PGPs) are plant-derived proteins with sugar moieties covalently linked to amino acid side chains, formed by glycosylation during posttranslational modification of polypeptides. Several studies in the last two decades, including cell culture and animal studies, have documented a variety of health-beneficial effects of PGPs, including hypolipidemic, wound healing, antioxidant, anti-inflammatory, immunomodulatory, and anticancer properties. Despite the prospects, there is a dearth of information on the pharmacokinetics and toxicity of PGPs, including possible induction of immune reactions, and the potential effects of stereospecific variation in PGPs isomers on their physiological functions. Further exploration of the multifunctional glycoproteins will position them as strong candidates for the development of nutraceuticals and functional foods

A Review on the Molecular Mechanisms of Action of Natural Products in Preventing Bone Diseases

The drugs used for treating bone diseases (BDs), at present, elicit hazardous side effects that include certain types of cancers and strokes, hence the ongoing quest for the discovery of alternatives with little or no side effects. Natural products (NPs), mainly of plant origin, have shown compelling promise in the treatments of BDs, with little or no side effects. However, the paucity in knowledge of the mechanisms behind their activities on bone remodeling has remained a hindrance to NPs’ adoption. This review discusses the pathological development of some BDs, the NP-targeted components, and the actions exerted on bone remodeling signaling pathways (e.g., Receptor Activator of Nuclear Factor κ B-ligand (RANKL)/monocyte/macrophage colony-stimulating factor (M-CSF)/osteoprotegerin (OPG), mitogen-activated protein kinase (MAPK)s/c-Jun N-terminal kinase (JNK)/nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), Kelch-like ECH-associated protein 1 (Keap-1)/nuclear factor erythroid 2–related factor 2 (Nrf2)/Heme Oxygenase-1 (HO-1), Bone Morphogenetic Protein 2 (BMP2)-Wnt/β-catenin, PhosphatidylInositol 3-Kinase (PI3K)/protein kinase B (Akt)/Glycogen Synthase Kinase 3 Beta (GSK3β), and other signaling pathways). Although majority of the studies on the osteoprotective properties of NPs against BDs were conducted ex vivo and mostly on animals, the use of NPs for treating human BDs and the prospects for future development remain promising

Lupin-Derived Bioactive Peptides: Intestinal Transport, Bioavailability and Health Benefits

There is a renewed interest on the reliance of food-based bioactive compounds as sources of nutritive factors and health-beneficial chemical compounds. Among these food components, several proteins from foods have been shown to promote health and wellness as seen in proteins such as α/γ-conglutins from the seeds of Lupinus species (Lupin), a genus of leguminous plant that are widely used in traditional medicine for treating chronic diseases. Lupin-derived peptides (LDPs) are increasingly being explored and they have been shown to possess multifunctional health improving properties. This paper discusses the intestinal transport, bioavailability and biological activities of LDPs, focusing on molecular mechanisms of action as reported in in vitro, cell culture, animal and human studies. The potentials of several LDPs to demonstrate multitarget mechanism of regulation of glucose and lipid metabolism, chemo- and osteoprotective properties, and antioxidant and anti-inflammatory activities position LDPs as good candidates for nutraceutical development for the prevention and management of medical conditions whose etiology are multifactorial

Comparative Study on the Nutritional Properties of Citrullus colocynthis, Irvingia gabonensis and I. wombolu Seeds

Background: The effects of malnutrition due to food insecurity demand continuous and urgent efforts to salvage the situations. There are needs to compare the nutritional and anti-nutritional status of edible plant materials commonly used to help consumers make a scientific-based informed decision.Objective: to determine and compare the nutritional and anti-nutritional contents of three seeds - Citrullus colocynthis, Irvingia gabonensis and I. wombolu.Materials and methods: The seeds sourced from Nsukka Market and were analyzed for mineral, proximate, vitamin and anti-nutrient compositions using standard protocols.Results: The concentration of sodium, copper, magnesium, zinc and phosphorous were higher in C. colocynthis seed compared to Irvingia species. I. wombolu had the highest calcium, and potassium contents. I. gabonensis had the highest iron content. C. colocynthis had the highest protein content, while the two Irvingia seeds had higher total fats, fatty acids, and calorific values compared to C. colocynthis seed. Vitamin C, in C. colocynthis was the least total vitamin content and the least antinutrient.Conclusion: This study demonstrates that seeds of Citrullus colocynthis, Irvingia gabonensis and I. wombolu are rich in nutritive factors, in varying proportions, and are low in antinutrient contents. With the results of this comparative study, consumers are therefore encouraged to make evidence-based decision on the choice of the seed to consume in line with their nutritional and health needs